---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-26-000045"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2026-08-03T20:03:40+00:00"
generated_at: "2026-08-03T20:04:24.725893+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q2 revenue down 7.6% to $200.6M; raises FY2026 guidance; announces Project Horizon restructuring

## Summary
- Q2 revenue $200.6M (-7.6% YoY); diluted EPS $0.01, adjusted diluted EPS $0.14.
- Gross margin 85.5% (+150 bps); operating cash flow $23.2M vs $2.7M prior year.
- Raised FY2026 revenue guidance to $835M-$875M; adjusted diluted EPS guidance $1.05-$1.45.
- Announced Project Horizon restructuring to generate $30M annualized growth investment capacity; expects $20M-$25M pre-tax charges.
- Cash and investments $415.2M as of June 30, 2026.

## SEC filing metadata
- accession: 0001609550-26-000045
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2026-08-03T20:03:40+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955026000045/0001609550-26-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955026000045/insp-20260803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-26-000045
- JSON: https://secwatch.observer/filing/0001609550-26-000045.json
- Plain text: https://secwatch.observer/filing/0001609550-26-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.